SEP 10, 2020 10:20 PM PDT

Researchers Will Be Allowed To Use State-Licensed Cannabis for Research

WRITTEN BY: Angela Dowden

Cannabis researchers in the U.S. have often had their research efforts frustrated by the difficulties in being able to access marijuana and marijuana products. The problem has been that privately grown cannabis—even from state-licensed and compliant manufacturers—was not allowed in FDA-approved clinical trials. Instead, investigators were only allowed to obtain whole-plant cannabis from a single source: the University of Mississippi, which since 1968 was the only federally licensed source of cannabis cultivated for research purposes.

The good news is that change is afoot and quickly, following a September 9, 2020 vote by members of the House Energy and Commerce Committee to amend Congressman Earl Blumenauer’s HR 3797 bill: “The Marijuana Research Act of 2019”. The amended legislation expedites an approval process for newly-allowed federal cultivation applicants, and provides scientists with the option to utilize products manufactured by these state-licensed sources, not just the old official source.

 “The bipartisan support of our legislation in [this] committee mark-up is an important step in removing unnecessary barriers to medical cannabis research and ensuring that patients, clinicians, and consumers can fully understand the benefits and risks of cannabis,” Rep. Blumenauer said.

Deputy Director Paul Armentano from the National Organization for the Reform of Marijuana Laws (NORML) added that the new bill will “facilitate and expedite clinical cannabis research in the United States and provide important data regarding the safety and efficacy of real-world products.”

He added: “Rather than compelling scientists to access marijuana products of questionable quality manufactured by a limited number of federally licensed producers, federal regulators should allow investigators to access the cannabis and cannabis-infused products that are currently being produced in the legal marketplace by the multitude of state-sanctioned growers and retailers”.

Scientists have consistently criticized the poor quality of the University of Mississippi’s plants, which they say fail to accurately reflect the varieties of marijuana commercially available. For example scientists have only been able to select six varieties of pre-rolled cannabis cigarettes—none of which possess THC concentrations above seven percent—from the federal government’s marijuana menu, and tinctures and concentrates have not been available for clinical study at all.

Source: NORML

About the Author
  • I'm a journalist and author with many year's experience of writing for both a consumer and professional audience, mostly on nutrition, health and medical prescribing. My background is food science and I'm a registered nutritionist.
You May Also Like
APR 01, 2021
Health & Medicine
60 Percent of Texans Using Cannabis Prefer it Over Conventional Drugs
APR 01, 2021
60 Percent of Texans Using Cannabis Prefer it Over Conventional Drugs
A new survey out of Texas has revealed that 61 percent of people in the state who identify as medicinal cannabis users h ...
APR 04, 2021
Microbiology
A Nanoparticle-Based Universal Flu Vaccine Moves Closer to Use
APR 04, 2021
A Nanoparticle-Based Universal Flu Vaccine Moves Closer to Use
There are many different influenza viruses, which cause from 290,000 to 650,000 deaths every year. That range depends on ...
APR 05, 2021
Microbiology
Salmonella Outbreaks Linked to Bird Feeders, Pet Turtles
APR 05, 2021
Salmonella Outbreaks Linked to Bird Feeders, Pet Turtles
Many types of bacteria often live harmlessly in and on animals and humans, but some bacteria pose a threat. Salmonella b ...
APR 07, 2021
Genetics & Genomics
New Approach Reveals 13 Novel Alzheimer's-Linked Genes
APR 07, 2021
New Approach Reveals 13 Novel Alzheimer's-Linked Genes
Scientists have been using genetic and computational tools to find small changes in the sequences of genes that are like ...
APR 08, 2021
Health & Medicine
Patented Mix of Terpenes and CBD Has Potential to Help COVID
APR 08, 2021
Patented Mix of Terpenes and CBD Has Potential to Help COVID
Israeli-based technology firm Eybna, who specialize in isolating and testing components from the cannabis plant, say tha ...
APR 12, 2021
Cannabis Sciences
How Long Does a Cannabis High Last?
APR 12, 2021
How Long Does a Cannabis High Last?
How long a cannabis high lasts can be very subjective. It is, however, an important matter when considering drug-driving ...
Loading Comments...